Effect Of Obesity On Ozone-Induced Airway Inflammation

NCT ID: NCT00839943

Last Updated: 2012-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-05-31

Study Completion Date

2012-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effect of ozone exposure on airway reactivity and inflammation in obese vs. non-obese adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity has been shown to be associated with initial onset of asthma in children and increased airway hyperresponsiveness in adults (1,2). An important aspect of these epidemiologic data is that the impact of obesity on asthma is much stronger in females than males. For example, the incidence of asthma after the age of 11 years is five- to sevenfold higher in female children who become obese versus those who remain lean, whereas no such relationship exists for males (3). Recent mouse models of obesity suggest that this condition enhances airway responses to ozone air pollution (4). These mice eat excessively due to a defect in the gene encoding leptin, a satiety hormone produced in adipocytes. Shore et al (4) showed that these leptin-deficient obese mice had greater airway hyperreactivity to i.v. methacholine following ozone exposure compared to lean, wild-type mice. Furthermore, administration of exogenous leptin (which is actually increased in the serum of obese individuals (4)) was shown to enhance ozone-induced cytokine and protein release into BAL fluid of lean, wild type mice (4). Reduced lung volumes and altered breathing patterns in the obese may also contribute to enhanced airway reactivity in these patients (5). Stretch of airway smooth muscle during tidal breathing and especially during deep breaths, i.e. sighs, acts as a potent bronchodilator that might ameliorate ozone-induced bronchoconstriction. The increased chest load associated with obesity may also diminish tidal breathing volumes and frequency of sighs during ozone exposure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

ozone clean air

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ozone

obese vs non-obese women

Group Type ACTIVE_COMPARATOR

ozone, 0.4 ppm

Intervention Type OTHER

2 hour ozone exposure, 0.40 ppm

air

obese vs non obese women

Group Type ACTIVE_COMPARATOR

ozone, 0.4 ppm

Intervention Type OTHER

2 hour ozone exposure, 0.40 ppm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ozone, 0.4 ppm

2 hour ozone exposure, 0.40 ppm

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Twenty (20) non-obese, non-overweight (body mass index, 18 kg/m2 \> BMI \< 25 kg/m2, waist circumference \< 35 inches) subjects and 20 obese (30 kg/m2 \> BMI \< 38 kg/m2, waist circumference \>= 35 inches) volunteer females between 18-35 yrs of age

Exclusion Criteria

* Are female and pregnant or have any reason to believe you might be pregnant.
* Are not between 18 and 35 years old.
* Have a history of asthma or have current hay fever.
* Have ever smoked more than 10 cigarettes (one half pack) a month or smoked during the past 30 days.
* Have a history of acute or chronic cardiovascular disease, chronic respiratory disease, and acute respiratory illness within 4 weeks.
* Have contraindications for performing sustained light exercise.
* You've been in a recent or recurring exposure to a dusty environment at work
* If you are unwilling to refrain from strenuous physical activity for 24 hours before and after each exposure.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

National Institute of Environmental Health Sciences (NIEHS)

NIH

Sponsor Role collaborator

Environmental Protection Agency (EPA)

FED

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

William Bennett, PhD

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Stephanie London, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

National Institute of Environmental Health Sciences (NIEHS)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

US EPA Human Studies Facility-UNC -CH campus

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB 05-1644

Identifier Type: -

Identifier Source: secondary_id

05-CEMLB-128

Identifier Type: -

Identifier Source: org_study_id